{
  "id": "0fb670fcf824a8e5",
  "title": "Dr Stein on the FDA Approval of Revumenib for R / R , NPM1 - Mutant AML",
  "description": "20251216T204500Z",
  "content": "",
  "source": "onclive.com",
  "source_url": "https://www.onclive.com/view/dr-stein-on-the-fda-approval-of-revumenib-for-r-r-npm1-mutant-aml",
  "published_at": "20251216T204500Z",
  "fetched_at": "2025-12-17T00:22:43.797460+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.onclive.com/view/dr-stein-on-the-fda-approval-of-revumenib-for-r-r-npm1-mutant-aml",
    "url_mobile": "",
    "title": "Dr Stein on the FDA Approval of Revumenib for R / R , NPM1 - Mutant AML",
    "seendate": "20251216T204500Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/onclive/2f234c34063361dc7c6fec980c436cd357e1f9e9-1280x720.jpg",
    "domain": "onclive.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}